Diets for inflammatory bowel disease: What do we know so far?
Journal
European journal of clinical nutrition
ISSN: 1476-5640
Titre abrégé: Eur J Clin Nutr
Pays: England
ID NLM: 8804070
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
04
01
2021
accepted:
17
11
2021
revised:
11
11
2021
pubmed:
23
1
2022
medline:
9
9
2022
entrez:
22
1
2022
Statut:
ppublish
Résumé
In recent years, the role of diet in the pathogenesis of inflammatory bowel disease (IBD) has gained great interest within the scientific community. Eating habits from industrialised countries (the so-called western diet or WD) have been associated with a higher incidence of IBD in observational studies, although the dietary factors responsible for the development of the disease are still to be elucidated. Some components of the diet with proinflammatory potential may cause changes in immunity and intestinal microbiota, leading to the inflammatory reaction that causes IBD-related lesions. The quality of available evidence is low, due to methodological issues, such as the lack of intervention studies, small sample size and heterogeneity of studies. For this reason, scientific societies have offered their recommendations using clinical practice guidelines and consensus documents, in order to establish a common criterion in the nutritional treatment of patients with IBD. The objective of this review was to summarise the data published regarding diet in IBD and review the recommendations given by scientific societies.
Identifiants
pubmed: 35064219
doi: 10.1038/s41430-021-01051-9
pii: 10.1038/s41430-021-01051-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1222-1233Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet Lond Engl. 2018;390:2769–78. 23 de
doi: 10.1016/S0140-6736(17)32448-0
Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630–49.
pubmed: 23335431
doi: 10.1136/gutjnl-2012-303661
Damas OM, Estes D, Avalos D, Quintero MA, Morillo D, Caraballo F, et al. Hispanics coming to the US adopt US cultural behaviors and eat less healthy: implications for development of inflammatory bowel disease. Dig Dis Sci. 2018;63:3058–66.
pubmed: 29982988
pmcid: 6182439
doi: 10.1007/s10620-018-5185-2
Sigall Boneh R, Levine A, Lomer M, Wierdsma N, Alan P, Fiorino G, et al. Research gaps in diet and nutrition in inflammatory bowel disease. A topical review by ECCO. J Crohns Colitis. 2017;11:S28-9.
Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Nimptsch K, et al. High school diet and risk of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2015;21:2311–9.
pubmed: 26236952
Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2013;145:970–7.
pubmed: 23912083
doi: 10.1053/j.gastro.2013.07.050
Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut 2014;63:776–84.
pubmed: 23828881
doi: 10.1136/gutjnl-2013-305304
Li F, Liu X, Wang W, Zhang D. Consumption of vegetables and fruit and the risk of inflammatory bowel disease: a meta-analysis. Eur J Gastroenterol Hepatol. 2015;27:623–30.
pubmed: 25831134
doi: 10.1097/MEG.0000000000000330
IBD in EPIC Study Investigators, Tjonneland A, Overvad K, Bergmann MM, Nagel G, Linseisen J, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut. 2009;58:1606–11.
doi: 10.1136/gut.2008.169078
Chan SS. Docosahexanoeic acid and eicosapentaenoic acid in the aetiology of crohn’s disease-data from a European prospective cohort study (EPIC). Gastroenterology 2012;142:S791.
Racine A, Carbonnel F, Chan SSM, Hart AR, Bueno-de-Mesquita HB, Oldenburg B, et al. Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC Study. Inflamm Bowel Dis. 2016;22:345–54.
pubmed: 26717318
doi: 10.1097/MIB.0000000000000638
Vasseur P, Dugelay E, Benamouzig R, Savoye G, Lan A, Srour B, et al. Dietary patterns, ultra-processed food, and the risk of inflammatory bowel diseases in the NutriNet-Santé Cohort. Inflamm Bowel Dis. 2021;27:65–73.
pubmed: 32055825
doi: 10.1093/ibd/izaa018
Bischoff SC. ESPEN practical guideline: clinical nutrition in inflammatory bowel disease. Clin Nutr. 2020;39:632–53.
pubmed: 32029281
doi: 10.1016/j.clnu.2019.11.002
Birchenough G, Schroeder BO, Bäckhed F, Hansson GC. Dietary destabilisation of the balance between the microbiota and the colonic mucus barrier. Gut Microbes. 2019;10:246–50.
pubmed: 30252606
doi: 10.1080/19490976.2018.1513765
Le Leu RK, Young GP, Hu Y, Winter J, Conlon MA. Dietary red meat aggravates dextran sulfate sodium-induced colitis in mice whereas resistant starch attenuates inflammation. Dig Dis Sci. 2013;58:3475–82.
pubmed: 23990000
doi: 10.1007/s10620-013-2844-1
Ijssennagger N, Belzer C, Hooiveld GJ, Dekker J, van Mil SWC, Müller M, et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci USA. 2015;112:10038–43.
pubmed: 26216954
pmcid: 4538683
doi: 10.1073/pnas.1507645112
Partridge D, Lloyd KA, Rhodes JM, Walker AW, Johnstone AM, Campbell BJ. Food additives: assessing the impact of exposure to permitted emulsifiers on bowel and metabolic health—introducing the FADiets study. Nutr Bull. 2019;44:329–49.
pubmed: 31866761
pmcid: 6899614
doi: 10.1111/nbu.12408
Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. Negative effects of a high-fat diet on intestinal permeability: a review. Adv Nutr. 2020;11:77–91.
pubmed: 31268137
doi: 10.1093/advances/nmz061
de Silva PSA, Luben R, Shrestha SS, Khaw KT, Hart AR. Dietary arachidonic and oleic acid intake in ulcerative colitis etiology: a prospective cohort study using 7-day food diaries. Eur J Gastroenterol Hepatol. 2014;26:11–8.
pubmed: 24216567
doi: 10.1097/MEG.0b013e328365c372
McCormick NM, Logomarsino JV. The specific carbohydrate diet in the treatment of Crohn’s disease: a systematic review. J Gastroenterol Hepatol Res. 2017;6:2392–9.
doi: 10.17554/j.issn.2224-3992.2017.06.688
McGuckin MA, Lindén SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat Rev Microbiol. 2011;9:265–78.
pubmed: 21407243
doi: 10.1038/nrmicro2538
Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167:1339–1353.
pubmed: 27863247
pmcid: 5131798
doi: 10.1016/j.cell.2016.10.043
Pituch-Zdanowska A, Banaszkiewicz A, Albrecht P. The role of dietary fibre in inflammatory bowel disease. Prz Gastroenterol. 2015;10:135–41.
pubmed: 26516378
pmcid: 4607699
Celiberto LS, Graef FA, Healey GR, Bosman ES, Jacobson K, Sly LM, et al. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome. Immunology 2018;155:36–52.
pubmed: 29693729
pmcid: 6099178
doi: 10.1111/imm.12939
Limdi JK, Aggarwal D, McLaughlin JT. Dietary practices and beliefs in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:164–70.
pubmed: 26383912
doi: 10.1097/MIB.0000000000000585
Guadagnoli L, Mutlu EA, Doerfler B, Ibrahim A, Brenner D, Taft TH. Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. Qual Life Res. 2019;28:2195–205.
pubmed: 30900206
pmcid: 6625837
doi: 10.1007/s11136-019-02170-4
Bergeron F, Bouin M, D’Aoust L, Lemoyne M, Presse N. Food avoidance in patients with inflammatory bowel disease: what, when and who? Clin Nutr. 2018;37:884–9.
pubmed: 28359542
doi: 10.1016/j.clnu.2017.03.010
Macedo C, Portela F, Ferreira AM, Lopes S, Mendes S, Ferreira M, et al. Dietary restrictions on inflammatory bowel disease. J Crohns Colitis. 2019;13:S342.
doi: 10.1093/ecco-jcc/jjy222.586
Tomar SK, Kedia S, Upadhyay AD, Bopanna S, Yadav DP, Goyal S, et al. Impact of dietary beliefs and practices on patients with inflammatory bowel disease: an observational study from India. JGH Open. 2017;1:15–21.
pubmed: 30483527
pmcid: 6207045
doi: 10.1002/jgh3.12002
Opstelten JL, de Vries JHM, Wools A, Siersema PD, Oldenburg B, Witteman BJM. Dietary intake of patients with inflammatory bowel disease: a comparison with individuals from a general population and associations with relapse. Clin Nutr Edinb Scotl. 2019;38:1892–8.
doi: 10.1016/j.clnu.2018.06.983
Crooks B, Limdi JK, McLaughlin JT. Dietary practices and beliefs of patients with inactive ulcerative colitis: a prospective study from the United Kingdom. Proc Nutr Soc. 2020;79. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L630723143 .
Crooks B, Limdi JK, McLaughlin JT. Dietary practices and beliefs of patients with older-onset inflammatory bowel disease: a prospective study from the United Kingdom. Proc Nutr Soc. 2020;79:E21.
doi: 10.1017/S0029665119001423
Cohen AB, Lee D, Long MD, Kappelman MD, Martin CF, Sandler RS, et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013;58:1322–8.
pubmed: 22923336
doi: 10.1007/s10620-012-2373-3
Lim H-S, Kim S-K, Hong S-J. Food elimination diet and nutritional deficiency in patients with inflammatory bowel disease. Clin Nutr Res. 2018;7:48–55.
pubmed: 29423389
pmcid: 5796923
doi: 10.7762/cnr.2018.7.1.48
Walton M, Alaunyte I. Do patients living with ulcerative colitis adhere to healthy eating guidelines? A cross-sectional study. Br J Nutr. 2014;112:1628–35.
pubmed: 25247445
doi: 10.1017/S0007114514002074
Casanova MJ, Chaparro M, Molina B, Merino O, Batanero R, Dueñas-Sadornil C, et al. Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease. J Crohns Colitis. 2017;11:1430–9.
pubmed: 28981652
doi: 10.1093/ecco-jcc/jjx102
Nguyen GC, Munsell M, Harris ML. Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients. Inflamm Bowel Dis. 2008;14:1105–11.
pubmed: 18302272
doi: 10.1002/ibd.20429
Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, et al. Dietary guidance for patients with inflammatory bowel disease from the international organization for the study of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2020;18:1381–92.
pubmed: 32068150
doi: 10.1016/j.cgh.2020.01.046
Sood A, Ahuja V, Kedia S, Midha V, Mahajan R, Mehta V, et al. Diet and inflammatory bowel disease: The Asian Working Group guidelines. Indian J Gastroenterol. 2019;38:220–46.
pubmed: 31352652
pmcid: 6675761
doi: 10.1007/s12664-019-00976-1
Colombel J-F, Shin A, Gibson PR. AGA clinical practice update on functional gastrointestinal symptoms in patients with inflammatory bowel disease: expert review. Clin Gastroenterol Hepatol. 2019;17:380–390.e1.
pubmed: 30099108
doi: 10.1016/j.cgh.2018.08.001
Roszkowska A, Pawlicka M, Mroczek A, Balabuszek K, Nieradko-Iwanicka B. Non-celiac gluten sensitivity: a review. Medicina (Kaunas). 2019;55:222.
doi: 10.3390/medicina55060222
Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut 2017;66:1517–27.
pubmed: 28592442
doi: 10.1136/gutjnl-2017-313750
Sugihara K, Morhardt TL, Kamada N. The role of dietary nutrients in inflammatory bowel disease. Front Immunol. 2018;9:3183.
pubmed: 30697218
doi: 10.3389/fimmu.2018.03183
Testa A, Imperatore N, Rispo A, Rea M, Tortora R, Nardone OM, et al. Beneficial effect of a low fodmaps diet in different gastrointestinal disorders. United Eur Gastroenterol J. 2017;5:A741.
Zhan Y, Zhan Y-A, Dai S-X. Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review. Clin Nutr Edinb Scotl. 2018;37:123–9.
doi: 10.1016/j.clnu.2017.05.019
Bodini G, Zanella C, Crespi M, Lo Pumo S, Demarzo MG, Savarino E, et al. A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease. Nutr Burbank. 2019;67-68:110542.
doi: 10.1016/j.nut.2019.06.023
Cox SR, Stagg AJ, Fromentin S, Ehrlich SD, McCarthy NE, Galleron N, et al. Low FODMAP diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria and faecali bacterium Prausnitzii in quiescent inflammatory bowel disease: a randomised controlled trial and metagenomic analysis. Gastroenterology 2018;154:S–177.
doi: 10.1016/S0016-5085(18)31004-7
Pedersen N, Ankersen DV, Felding M, Wachmann H, Végh Z, Molzen L, et al. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol. 2017;23:3356–66. 14 de mayo de
pubmed: 28566897
pmcid: 5434443
doi: 10.3748/wjg.v23.i18.3356
Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Muir JG, Gibson PR. Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with Crohn’s disease: a randomised, controlled cross-over trial of well-defined diets. Clin Transl Gastroenterol. 2016;7:e164.
pubmed: 27077959
pmcid: 4855163
doi: 10.1038/ctg.2016.22
Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology 2020;158:176–188. e7
pubmed: 31586453
doi: 10.1053/j.gastro.2019.09.024
Maagaard L, Ankersen DV, Végh Z, Burisch J, Jensen L, Pedersen N, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol. 2016;22:4009–19.
pubmed: 27099444
pmcid: 4823251
doi: 10.3748/wjg.v22.i15.4009
Hwang C, Ross V, Mahadevan U. Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit. Inflamm Bowel Dis. 2014;20:732–41.
pubmed: 24562173
doi: 10.1097/01.MIB.0000438427.48726.b0
Manceñido Marcos N, Pajares Villarroya R, Salinas Moreno S, Arribas López MR, Comas Redondo C. The association between de novo inflammatory bowel disease and celiac disease. Rev Esp Enferm Dig. 2020;112:7–11.
pubmed: 31718200
Bengi G, Civak M, Akarsu M, Soytürk M, Ellidokuz E, Topalak Ö, et al. Prevalance of celiac disease in patients with inflammatory bowel disease in Turkish population. Gastroenterol Res Pract. 2019;2019:6272098.
Aziz I, Branchi F, Pearson K, Priest J, Sanders DS. A study evaluating the bidirectional relationship between inflammatory bowel disease and self-reported non-celiac gluten sensitivity. Inflamm Bowel Dis. 2015;21:847–53. abril de
pubmed: 25719528
doi: 10.1097/MIB.0000000000000335
Limketkai BN, Sepulveda R, Hing T, Shah ND, Choe M, Limsui D, et al. Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease. Scand J Gastroenterol. 2018;53:147–51.
pubmed: 29216767
doi: 10.1080/00365521.2017.1409364
Herfarth HH, Martin CF, Sandler RS, Kappelman MD, Long MD. Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2014;20:1194–7.
pubmed: 24865778
doi: 10.1097/MIB.0000000000000077
Gibson PR. Use of the low-FODMAP diet in inflammatory bowel disease. J Gastroenterol Hepatol. 2017;32(Suppl 1):40–2.
pubmed: 28244679
doi: 10.1111/jgh.13695
Kaplan HC, Opipari-Arrigan L, Schmid CH, Schuler CL, Saeed S, Braly KL, et al. Evaluating the Comparative effectiveness of two diets in pediatric inflammatory bowel disease: a study protocol for a series of N-of-1 trials. Healthcare (Basel) 2019;7.
Burgis JC, Nguyen K, Park KT, Cox K. Response to strict and liberalized specific carbohydrate diet in pediatric Crohn’s disease. World J Gastroenterol. 2016;22:2111–7.
pubmed: 26877615
pmcid: 4726683
doi: 10.3748/wjg.v22.i6.2111
Cohen SA, Gold BD, Oliva S, Lewis J, Stallworth A, Koch B, et al. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2014;59:516–21.
pubmed: 24897165
doi: 10.1097/MPG.0000000000000449
Suskind DL, Wahbeh G, Cohen SA, Damman CJ, Klein J, Braly K, et al. Patients perceive clinical benefit with the specific carbohydrate diet for inflammatory bowel disease. Dig Dis Sci. 2016;61:3255–60.
pubmed: 27638834
doi: 10.1007/s10620-016-4307-y
Vincenzi M, Paolini B, Del Ciondolo I, Pasquini E, Ceccarelli L, Gennai K, et al. Effects on symptoms and on nutritional adequacy of a low fodmaps diet and specific carbohydrate diet on inflammatory bowel disease. Double blind and randomized study. Preliminary Result Gastroenterol. 2016;150:S425.
Jarmakiewicz-Czaja S, Piątek D, Filip R. The influence of nutrients on inflammatory bowel diseases. J Nutr Metab. 2020;2020:2894169.
pubmed: 32190385
pmcid: 7064842
doi: 10.1155/2020/2894169
Szilagyi A, Galiatsatos P, Xue X. Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J. 2016;15:67. 13 de
pubmed: 27411934
pmcid: 4942986
doi: 10.1186/s12937-016-0183-8
Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr. 2004;23:161–70.
pubmed: 15030955
doi: 10.1016/S0261-5614(03)00132-8
Opstelten JL, Leenders M, Dik VK, Chan SSM, van Schaik FDM, Khaw K-T, et al. Dairy products, dietary calcium, and risk of inflammatory bowel disease: results from a European prospective cohort investigation. Inflamm Bowel Dis. 2016;22:1403–11.
pubmed: 27120568
doi: 10.1097/MIB.0000000000000798
Brasil Lopes M, Rocha R, Castro Lyra A, Rosa Oliveira V, Gomes Coqueiro F, Silveira Almeida N, et al. Restriction of dairy products; a reality in inflammatory bowel disease patients. Nutr Hosp. 2014;29:575–81.
pubmed: 24559002
Bernstein CN, Ament M, Artinian L, Ridgeway J, Shanahan F. Milk tolerance in adults with ulcerative colitis. Am J Gastroenterol. 1994;89:872–7.
pubmed: 8198097
Ahishali E, Akkus EE, Dolapcioglu C, Sayiner M, Arslan T, Yilmaz R, et al. Assessment of lactose intolerance in ulcerative colitis patients on remission. J Crohns Colitis. 2015;9:S351.
doi: 10.1093/ecco-jcc/jju027.661
Menezes C, Rocha R, Coqueiro F, Lopes M, Nunes P, Sales L, et al. Lactose intolerance in inflammatory bowel disease patients. J Crohns Colitis. 2013;7:S91.
doi: 10.1016/S1873-9946(13)60227-5
Jasielska M, Grzybowska-Chlebowczyk U. Lactose malabsorption and lactose intolerance in children with inflammatory bowel diseases. Gastroenterol Res Pract. 2019;2019:1–6.
doi: 10.1155/2019/2507242
Eadala P, Matthews SB, Waud JP, Green JT, Campbell AK. Association of lactose sensitivity with inflammatory bowel disease-demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Aliment Pharm Ther. 2011;34:735–46.
doi: 10.1111/j.1365-2036.2011.04799.x
Vernia P, Loizos P, Di Giuseppantonio I, Amore B, Chiappini A, Cannizzaro S. Dietary calcium intake in patients with inflammatory bowel disease. J Crohns Colitis. 2014;8:312–7.
pubmed: 24090907
doi: 10.1016/j.crohns.2013.09.008
Lopes M, Rocha R, Oliveira V, Coqueiro F, Menezes C, Silveira N, et al. Dairy food consumption by patients with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:S36.
doi: 10.1097/00054725-201212001-00085
Silvennoinen J, Lamberg-Allardt C, Kärkkäinen M, Niemelä S, Lehtola J. Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med. 1996;240:285–92. noviembre de
pubmed: 8946811
doi: 10.1046/j.1365-2796.1996.25862000.x
Larussa T, Suraci E, Marasco R, Imeneo M, Abenavoli L, Luzza F. Self-prescribed dietary restrictions are common in inflammatory bowel disease patients and are associated with low bone mineralization. Medicina (Kaunas). 2019;20:507.
doi: 10.3390/medicina55080507
Nolan-Clark D, Tapsell LC, Hu R, Han DY, Ferguson LR. Effects of dairy products on Crohn’s disease symptoms are influenced by fat content and disease location but not lactose content or disease activity status in a New Zealand population. J Am Diet Assoc. 2011;111:1165–72.
pubmed: 21802562
doi: 10.1016/j.jada.2011.05.004
Vagianos K, Sexton K, Bernstein M, Hu P, Zhao K, Bernstein CN, et al. Dietary lactose consumption is associated with both increased symptoms and intestinal inflammation in IBD. Gastroenterology 2016;150:S41–2.
doi: 10.1016/S0016-5085(16)30265-7
Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017;152:398–414.e6.
pubmed: 27793606
doi: 10.1053/j.gastro.2016.10.019
Liu X, Wu Y, Li F, Zhang D. Dietary fiber intake reduces risk of inflammatory bowel disease: result from a meta-analysis. Nutr Res. 2015;35:753–8.
pubmed: 26126709
doi: 10.1016/j.nutres.2015.05.021
Andersen V, Chan S, Luben R, Khaw K-T, Olsen A, Tjonneland A, et al. Fibre intake and the development of inflammatory bowel disease: a European prospective multi-centre cohort study (EPIC-IBD). J Crohns Colitis. 2018;12:129–36.
pubmed: 29373726
doi: 10.1093/ecco-jcc/jjx136
Anderson JL, Hedin CR, Benjamin JL, Koutsoumpas A, Ng SC, Hart AL, et al. Dietary intake of inulin-type fructans in active and inactive Crohn’s disease and healthy controls: a case-control study. J Crohns Colitis. 2015;9:1024–31.
pubmed: 26221003
doi: 10.1093/ecco-jcc/jjv136
Brotherton CS, Martin CA, Long MD, Kappelman MD, Sandler RS. Avoidance of fiber is associated with greater risk of crohn’s disease flare in a 6-month period. Clin Gastroenterol Hepatol. 2016;14:1130–6.
pubmed: 26748217
doi: 10.1016/j.cgh.2015.12.029
Godny L, Maharshak N, Reshef L, Goren I, Yahav L, Fliss-Isakov N, et al. Fruit consumption is associated with alterations in microbial composition and lower rates of pouchitis. J Crohns Colitis. 2019;13:1265–72.
pubmed: 30828722
doi: 10.1093/ecco-jcc/jjz053
Wedlake L, Slack N, Andreyev HJN, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis. 2014;20:576–86.
pubmed: 24445775
doi: 10.1097/01.MIB.0000437984.92565.31
Brotherton CS, Taylor AG, Bourguignon C, Anderson JG. A high-fiber diet may improve bowel function and health-related quality of life in patients with Crohn disease. Gastroenterol Nurs. 2014;37:206–16.
pubmed: 24871666
pmcid: 4260718
doi: 10.1097/SGA.0000000000000047
Tasson L, Canova C, Vettorato MG, Savarino E, Zanotti R. Influence of diet on the course of inflammatory bowel disease. Dig Dis Sci. 2017;62:2087–94.
pubmed: 28550491
doi: 10.1007/s10620-017-4620-0
Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. N. Engl J Med. 1985;312:283–9.
pubmed: 2981409
doi: 10.1056/NEJM198501313120505
Whalen KA, McCullough ML, Flanders WD, Hartman TJ, Judd S, Bostick RM. Paleolithic and Mediterranean diet pattern scores are inversely associated with biomarkers of inflammation and oxidative balance in adults. J Nutr. 2016;146:1217–26.
pubmed: 27099230
pmcid: 4877627
doi: 10.3945/jn.115.224048
Kyaw MH, Moshkovska T, Mayberry J. A prospective, randomized, controlled, exploratory study of comprehensive dietary advice in ulcerative colitis: impact on disease activity and quality of life. Eur J Gastroenterol Hepatol. 2014;26:910–7.
pubmed: 24942954
doi: 10.1097/MEG.0000000000000127
Levenstein S, Prantera C, Luzi C, D’Ubaldi A. Low residue or normal diet in Crohn’s disease: a prospective controlled study in Italian patients. Gut. 1985;26:989–93.
pubmed: 2996991
pmcid: 1432953
doi: 10.1136/gut.26.10.989
Koga H, Iida M, Aoyagi K, Matsui T, Fujishima M. [Long-term efficacy of low residue diet for the maintenance of remission in patients with Crohn’s disease]. Nihon Shokakibyo Gakkai Zasshi. 1993;90:2882–8.
pubmed: 8271460
Chiba M, Abe T, Tsuda H, Sugawara T, Tsuda S, Tozawa H, et al. Lifestyle-related disease in Crohn’s disease: relapse prevention by a semi-vegetarian diet. World J Gastroenterol. 2010;16:2484–95.
pubmed: 20503448
pmcid: 2877178
doi: 10.3748/wjg.v16.i20.2484
Chiba M, Tsuji T, Komatsu M. How to optimize effects of infliximab in inflammatory bowel disease: incorporation of a plant-based diet. Gastroenterology. 2020;158:1512.
pubmed: 31953070
doi: 10.1053/j.gastro.2019.12.050
Chiba M, Ishii H, Komatsu M. Recommendation of plant-based diets for inflammatory bowel disease. Transl Pediatr. 2019;8:23–7.
pubmed: 30881895
pmcid: 6382506
doi: 10.21037/tp.2018.12.02
Chiba M, Tsuji T, Nakane K, Komatsu M. High amount of dietary fiber not harmful but favorable for Crohn disease. Perm J. 2015;19:58–61.
pubmed: 25663207
pmcid: 4315379
doi: 10.7812/TPP/14-124
Chiba M, Nakane K, Tsuji T, Tsuda S, Ishii H, Ohno H, et al. Relapse prevention by plant-based diet incorporated into induction therapy for ulcerative colitis: a single-group trial. Perm J. 2019;23:18–220.
pubmed: 30624192
pmcid: 6499111
doi: 10.7812/TPP/18-220
Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N. Engl J Med. 2018;378:e34.
pubmed: 29897866
doi: 10.1056/NEJMoa1800389
Cárdeno A, Magnusson MK, Strid H, Alarcón de La Lastra C, Sánchez-Hidalgo M, Ohman L. The unsaponifiable fraction of extra virgin olive oil promotes apoptosis and attenuates activation and homing properties of T cells from patients with inflammatory bowel disease. Food Chem. 2014;161:353–60.
pubmed: 24837962
doi: 10.1016/j.foodchem.2014.04.016
Lo C-H, Khalili H, Song M, Lochhead P, Burke KE, Richter JM, et al. Healthy lifestyle is associated with reduced mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2021;19:87–95.e4.
pubmed: 32142939
doi: 10.1016/j.cgh.2020.02.047
Khalili H, Håkansson N, Chan SS, Chen Y, Lochhead P, Ludvigsson JF, et al. Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn’s disease: results from two large prospective cohort studies. Gut.2020;69:1697–44.
doi: 10.1136/gutjnl-2019-319505
Taylor L, Almutairdi A, Shommu N, Fedorak R, Ghosh S, Reimer RA, et al. Cross-sectional analysis of overall dietary intake and mediterranean dietary pattern in patients with Crohn’s disease. Nutrients. 2018;10:1761.
pmcid: 6266729
doi: 10.3390/nu10111761
Papada E, Amerikanou C, Forbes A, Kaliora AC. Adherence to Mediterranean diet in Crohn’s disease. Eur J Nutr. 2020;59:1115–21.
pubmed: 31006053
doi: 10.1007/s00394-019-01972-z
Godny L, Reshef L, Pfeffer-Gik T, Goren I, Yanai H, Tulchinsky H, et al. Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery. Eur J Nutr. 2020;59:3183–90.
pubmed: 31813010
doi: 10.1007/s00394-019-02158-3
Marlow G, Ellett S, Ferguson IR, Zhu S, Karunasinghe N, Jesuthasan AC, et al. Transcriptomics to study the effect of a Mediterranean-inspired diet on inflammation in Crohn’s disease patients. Hum Genomics. 2013;7:24.
pubmed: 24283712
pmcid: 4174666
doi: 10.1186/1479-7364-7-24
Morvaridi M, Jafarirad S, Seyedian SS, Alavinejad P, Cheraghian B. The effects of extra virgin olive oil and canola oil on inflammatory markers and gastrointestinal symptoms in patients with ulcerative colitis. Eur J Clin Nutr. 2020;74:891–9.
pubmed: 31901082
doi: 10.1038/s41430-019-0549-z
Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault M-C, Carbonnel F. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol. 2010;105:2195–201.
pubmed: 20461067
doi: 10.1038/ajg.2010.192
Rashvand S, Somi MH, Rashidkhani B, Hekmatdoost A. Dietary protein intakes and risk of ulcerative colitis. Med J Islam Repub Iran. 2015;29:253.
pubmed: 26793644
pmcid: 4715377
Ge J, Han TJ, Liu J, Li JS, Zhang XH, Wang Y, et al. Meat intake and risk of inflammatory bowel disease: a meta-analysis. Turk J Gastroenterol J Turk Soc Gastroenterol. 2015;26:492–7.
doi: 10.5152/tjg.2015.0106
Albenberg L, Brensinger CM, Wu Q, Gilroy E, Kappelman MD, Sandler RS, et al. A diet low in red and processed meat does not reduce rate of Crohn’s disease flares. Gastroenterology. 2019;157:128–136. e5
pubmed: 30872105
doi: 10.1053/j.gastro.2019.03.015
Mills SC, Windsor AC, Knight SC. The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin Exp Immunol. 2005;142:216–28.
pubmed: 16232207
pmcid: 1809520
doi: 10.1111/j.1365-2249.2005.02851.x
de Silva PS, Korzenik JR. Inflammatory bowel disease: a focus on the involvement of dietary fats. Int J Interferon Cytokine Mediat Res. 2014;6:19–25.
doi: 10.2147/IJICMR.S35997
Innis SM, Pinsk V, Jacobson K. Dietary lipids and intestinal inflammatory disease. J Pediatr. 2006;149(Suppl.):S89–96.
doi: 10.1016/j.jpeds.2006.06.058
Kuwabara A, Nakase H, Tsuji H, Shide K, Chiba T, Inagaki N, et al. Fat restriction is associated with impaired quality of life in patients with ulcerative colitis and Crohn’s disease. Ulcers. 2011. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L364545773 .
Leiper K, Woolner J, Mullan MM, Parker T, van der Vliet M, Fear S, et al. A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn’s disease. Gut. 2001;49:790–4.
pubmed: 11709513
pmcid: 1728544
doi: 10.1136/gut.49.6.790
Barnes EL, Nestor M, Onyewadume L, de Silva PS, Korzenik JR, DREAM Investigators. High dietary intake of specific fatty acids increases risk of flares in patients with ulcerative colitis in remission during treatment with aminosalicylates. Clin Gastroenterol Hepatol. 2017;15:1390–1396.
pubmed: 28110099
pmcid: 5515695
doi: 10.1016/j.cgh.2016.12.036
John S, Luben R, Shrestha SS, Welch A, Khaw K-T, Hart AR. Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol. 2010;22:602–6.
pubmed: 20216220
doi: 10.1097/MEG.0b013e3283352d05
Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: a case series report. Nutr J. 2014;13:5.
pubmed: 24428901
pmcid: 3896778
doi: 10.1186/1475-2891-13-5
Konijeti GG, Kim N, Lewis JD, Groven S, Chandrasekaran A, Grandhe S, et al. Efficacy of the autoimmune protocol diet for inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:2054–60.
pubmed: 28858071
doi: 10.1097/MIB.0000000000001221
Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut Oct de. 2004;53:1459–64.
doi: 10.1136/gut.2003.037697
Bentz S, Hausmann M, Piberger H, Kellermeier S, Paul S, Held L, et al. Clinical relevance of IgG antibodies against food antigens in Crohn’s disease: a double-blind cross-over diet intervention study. Digestion 2010;81:252–64.
pubmed: 20130407
doi: 10.1159/000264649
Gunasekeera V, Mendall MA, Chan D, Kumar D. Treatment of Crohn’s disease with an IgG4-guided exclusion diet: a randomized controlled trial. Dig Dis Sci. 2016;61:1148–57.
pubmed: 26809868
doi: 10.1007/s10620-015-3987-z
Rajendran N, Kumar D. Food-specific IgG4-guided exclusion diets improve symptoms in Crohn’s disease: a pilot study. Colorectal Dis. 2011;13:1009–13.
pubmed: 20626437
doi: 10.1111/j.1463-1318.2010.02373.x
Jian L, Anqi H, Gang L, Litian W, Yanyan X, Mengdi W, et al. Food exclusion based on IgG antibodies alleviates symptoms in ulcerative colitis: a prospective study. Inflamm Bowel Dis. 2018;24:1918–25.
pubmed: 29788288
doi: 10.1093/ibd/izy110
Chabane H, Doyen V, Bienvenu F, Adel-Patient K, Vitte J, Mariotte D, et al. Anti-food IgG assays: methods and clinical relevance of results. Position of the biology task force of the French society of allergy. Rev Fr Allergol. 2018;58:334–57.
doi: 10.1016/j.reval.2018.01.007
Stapel SO, Asero R, Ballmer-Weber BK, Knol EF, Strobel S, Vieths S, et al. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report. Allergy. 2008;63:793–6.
pubmed: 18489614
doi: 10.1111/j.1398-9995.2008.01705.x
Powell JJ, Thoree V, Pele LC. Dietary microparticles and their impact on tolerance and immune responsiveness of the gastrointestinal tract. Br J Nutr. 2007;98(Suppl 1):S59–63.
pubmed: 17922962
pmcid: 2737314
doi: 10.1017/S0007114507832922
Powell JJ, Faria N, Thomas-McKay E, Pele LC. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun. 2010;34:J226–233.
pubmed: 20096538
doi: 10.1016/j.jaut.2009.11.006
Lomer MCE, Hutchinson C, Volkert S, Greenfield SM, Catterall A, Thompson RPH, et al. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn’s disease. Br J Nutr. 2004;92:947–55.
pubmed: 15613257
doi: 10.1079/BJN20041276
Lomer MC, Harvey RS, Evans SM, Thompson RP, Powell JJ. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn’s disease. Eur J Gastroenterol Hepatol. 2001;13:101–6.
pubmed: 11246607
doi: 10.1097/00042737-200102000-00003
Lomer MCE, Grainger SL, Ede R, Catterall AP, Greenfield SM, Cowan RE. et al. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn’s disease. Eur J Gastroenterol Hepatol. 2005;17:377–84.
pubmed: 15716665
doi: 10.1097/00042737-200503000-00019